| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
26,335 |
23,889 |
$2.68M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,569 |
14,861 |
$904K |
| 80053 |
Comprehensive metabolic panel |
16,014 |
12,773 |
$434K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,273 |
1,961 |
$425K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,725 |
3,516 |
$409K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,340 |
1,944 |
$254K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,170 |
1,079 |
$117K |
| 87070 |
|
3,959 |
3,736 |
$111K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,435 |
1,931 |
$108K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
640 |
562 |
$96K |
| 87400 |
|
7,711 |
7,175 |
$73K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
111 |
103 |
$51K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,621 |
6,124 |
$41K |
| 81025 |
|
6,532 |
5,887 |
$39K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,478 |
1,174 |
$36K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
408 |
339 |
$34K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,273 |
1,621 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,561 |
2,890 |
$32K |
| A9270 |
Non-covered item or service |
6,663 |
1,402 |
$30K |
| 87040 |
|
1,823 |
1,153 |
$22K |
| 84484 |
|
5,393 |
3,461 |
$22K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,009 |
5,418 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
732 |
587 |
$21K |
| 81001 |
|
6,716 |
5,757 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,905 |
4,560 |
$20K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,187 |
3,139 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
4,908 |
4,093 |
$19K |
| J3490 |
Unclassified drugs |
939 |
616 |
$17K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
293 |
261 |
$17K |
| 85027 |
|
18,393 |
14,054 |
$16K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,872 |
8,192 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
1,814 |
1,633 |
$14K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,529 |
1,224 |
$13K |
| 76830 |
Ultrasound, transvaginal |
114 |
106 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,700 |
2,290 |
$11K |
| G0378 |
Hospital observation service, per hour |
1,856 |
898 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,884 |
2,677 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,859 |
4,658 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
600 |
486 |
$7K |
| 81003 |
|
3,484 |
3,098 |
$7K |
| 85610 |
|
3,549 |
2,805 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,078 |
1,017 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
187 |
126 |
$4K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
69 |
24 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,006 |
644 |
$4K |
| 87210 |
|
669 |
620 |
$4K |
| 73630 |
|
285 |
254 |
$4K |
| 87081 |
|
22 |
13 |
$4K |
| 83605 |
|
1,500 |
1,157 |
$3K |
| 72131 |
|
33 |
26 |
$3K |
| 83690 |
|
4,326 |
3,582 |
$3K |
| 85730 |
|
2,922 |
2,312 |
$3K |
| 73130 |
|
109 |
97 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,602 |
2,106 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
219 |
158 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,270 |
1,148 |
$2K |
| 84703 |
|
1,280 |
1,147 |
$2K |
| 73564 |
|
162 |
136 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
375 |
264 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
169 |
103 |
$2K |
| S0028 |
Injection, famotidine, 20 mg |
475 |
393 |
$1K |
| 73110 |
|
45 |
41 |
$1K |
| 85379 |
|
861 |
745 |
$1K |
| 84702 |
|
549 |
480 |
$1K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
49 |
40 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,085 |
1,024 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,614 |
2,769 |
$971.11 |
| 83735 |
|
2,210 |
1,600 |
$864.92 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,035 |
1,515 |
$795.28 |
| 73030 |
|
50 |
39 |
$756.21 |
| 76376 |
|
125 |
88 |
$735.67 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
204 |
185 |
$668.24 |
| 73610 |
|
123 |
106 |
$661.71 |
| 87420 |
|
1,013 |
973 |
$649.08 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
189 |
84 |
$611.36 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
84 |
70 |
$547.76 |
| 82150 |
|
1,593 |
1,349 |
$457.58 |
| 86900 |
|
674 |
523 |
$399.53 |
| 83880 |
|
824 |
660 |
$376.42 |
| 84443 |
Thyroid stimulating hormone (TSH) |
573 |
471 |
$330.96 |
| J7050 |
Infusion, normal saline solution, 250 cc |
284 |
187 |
$222.86 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,239 |
915 |
$164.37 |
| 96376 |
|
727 |
486 |
$73.30 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
32 |
26 |
$62.25 |
| 87186 |
|
151 |
116 |
$56.36 |
| 80061 |
Lipid panel |
90 |
71 |
$42.58 |
| 90714 |
|
28 |
28 |
$31.76 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
140 |
127 |
$31.06 |
| 82550 |
|
109 |
92 |
$6.00 |
| 86901 |
|
661 |
511 |
$4.40 |
| 84100 |
|
69 |
37 |
$1.66 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
138 |
62 |
$0.61 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
84 |
56 |
$0.00 |
| 85652 |
|
12 |
12 |
$0.00 |
| 87205 |
|
96 |
66 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
548 |
420 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
163 |
64 |
$0.00 |
| 86850 |
|
305 |
220 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16 |
13 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
19 |
13 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
77 |
58 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
77 |
63 |
$0.00 |
| 81002 |
|
32 |
29 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
16 |
14 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
33 |
12 |
$0.00 |
| 90715 |
|
15 |
13 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
37 |
13 |
$0.00 |
| 97163 |
|
16 |
12 |
$0.00 |